These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Molecular Pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology. Shen-Gunther J, Wang CM, Poage GM, Lin CL, Perez L, Banks NA, Huang TH. Clin Epigenetics; 2016; 8(1):96. PubMed ID: 27651839 [Abstract] [Full Text] [Related]
5. Genetic and epigenetic changes of HPV16 in cervical cancer differentially regulate E6/E7 expression and associate with disease progression. Mazumder Indra D, Singh RK, Mitra S, Dutta S, Chakraborty C, Basu PS, Mondal RK, Roychoudhury S, Panda CK. Gynecol Oncol; 2011 Dec; 123(3):597-604. PubMed ID: 21911249 [Abstract] [Full Text] [Related]
6. Viral DNA load, physical status and E2/E6 ratio as markers to grade HPV16 positive women for high-grade cervical lesions. Cricca M, Morselli-Labate AM, Venturoli S, Ambretti S, Gentilomi GA, Gallinella G, Costa S, Musiani M, Zerbini M. Gynecol Oncol; 2007 Sep; 106(3):549-57. PubMed ID: 17568661 [Abstract] [Full Text] [Related]
11. Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16. Hong D, Liu J, Hu Y, Lu X, Li B, Li Y, Hu D, Lu W, Xie X, Cheng X. BMC Cancer; 2017 Feb 15; 17(1):136. PubMed ID: 28202002 [Abstract] [Full Text] [Related]
13. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg. Latsuzbaia A, Hebette G, Fischer M, Arbyn M, Weyers S, Vielh P, Schmitt F, Mossong J. Diagn Cytopathol; 2017 May 15; 45(5):384-390. PubMed ID: 28247516 [Abstract] [Full Text] [Related]
14. Performance of HPV DNA testing with hybrid capture 2 in triaging women with minor cervical cytologic abnormalities (ASC-US/LSIL) in Northern Thailand. Khunamornpong S, Settakorn J, Sukpan K, Srisomboon J, Suprasert P, Siriaunkgul S. Asian Pac J Cancer Prev; 2014 May 15; 15(24):10961-6. PubMed ID: 25605209 [Abstract] [Full Text] [Related]
17. Diagnostic Utility of HPV16 E6 mRNA or E7 mRNA Quantitative Expression for Cervical Cells of Patients with Dysplasia and Carcinoma. Wu MZ, Li WN, Cha N, Tian LX, Zhang YI, Wu X, Guo KJ, Wu GP. Cell Transplant; 2018 Sep 15; 27(9):1401-1406. PubMed ID: 30056761 [Abstract] [Full Text] [Related]
18. Differential methylation of E2 binding sites in episomal and integrated HPV 16 genomes in preinvasive and invasive cervical lesions. Chaiwongkot A, Vinokurova S, Pientong C, Ekalaksananan T, Kongyingyoes B, Kleebkaow P, Chumworathayi B, Patarapadungkit N, Reuschenbach M, von Knebel Doeberitz M. Int J Cancer; 2013 May 01; 132(9):2087-94. PubMed ID: 23065631 [Abstract] [Full Text] [Related]
19. HPV16 E6 polymorphism and physical state of viral genome in relation to the risk of cervical cancer in women from the south of Poland. Szostek S, Zawilinska B, Klimek M, Kosz-Vnenchak M. Acta Biochim Pol; 2017 May 01; 64(1):143-149. PubMed ID: 27801430 [Abstract] [Full Text] [Related]